詳細検索

詳細検索

詳細検索

お問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/06/02 10:27

160.76 円

187.28 円

219.02 円

トピックス別レポート一覧 医療の市場調査レポート

    • 医療

 

US Computed Tomography (CT) Market Research Report By Types (Conventional Scanners (Low Slice, Medium Slice, High Slice), Cone Beam Scanners), By Applications (Oncology, Neurology, Cardiovascular, Musculoskeletal, Abdominal and Pelvic, Others), By End Users (Hospitals, Specialty Centres, Diagnostic and Imaging Centre), by Distribution Channel (Online Channels, Offline Channels) Forecast till 2032
US Computed Tomography (CT) Market Research Report By Types (Conventional Scanners (Low Slice, Medium Slice, High Slice), Cone Beam Scanners), By Applications (Oncology, Neurology, Cardiovascular, Musculoskeletal, Abdominal and Pelvic, Others), By End Users (Hospitals, Specialty Centres, Diagnostic and Imaging Centre), by Distribution Channel (Online Channels, Offline Channels) Forecast till 2032
価格 US$ 2,950  |  Market Research Future | 2026年5月 | 英文レポート
The US Computed Tomography Market was valued at USD 1,353.87 million in 2025 and is projected to reach USD 2,521.75 million by 2032. The market is expected to grow at a CAGR of 7.07% during the forecast period, driven by rising demand for advanced diagnos…
このレポートの詳細ページはこちら
Preeclampsia Therapeutics Market Research Report by Drug Class (Antihypertensive Drugs, Anticonvulsants, Corticosteroids, Others), by Disease Severity (Mild, Severe), by Route of Administration (Oral, Intravenous (IV), Intramuscular (IM)), by Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
Preeclampsia Therapeutics Market Research Report by Drug Class (Antihypertensive Drugs, Anticonvulsants, Corticosteroids, Others), by Disease Severity (Mild, Severe), by Route of Administration (Oral, Intravenous (IV), Intramuscular (IM)), by Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
価格 US$ 4,950  |  Market Research Future | 2026年5月 | 英文レポート
The global Preeclampsia Therapeutics Market was valued at USD 337.02 million in 2025 and is projected to reach USD 610.77 million by 2035. The market is expected to grow at a CAGR of 6.2% during the forecast period, driven by rising cases of hypertensive …
このレポートの詳細ページはこちら
Stress Urinary Incontinence Market Research Report by Product Type (Therapeutic or Interventional Devices, Absorbent Products), by End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centres, Home Care Settings, and others), by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
Stress Urinary Incontinence Market Research Report by Product Type (Therapeutic or Interventional Devices, Absorbent Products), by End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centres, Home Care Settings, and others), by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
価格 US$ 4,950  |  Market Research Future | 2026年5月 | 英文レポート
The global Stress Urinary Incontinence market was valued at USD 3,770.83 million in 2025 and is projected to reach USD 8,520.25 million by 2035. The market is expected to register a CAGR of 8.51% during the forecast period, driven by the growing prevalenc…
このレポートの詳細ページはこちら
Womens Health Market Research Report by Product (Contraceptive, Fertility and Ovulation Induction Drugs, Vaginal and Uterine Products, Bone Health Agents, Pain and Symptom Management, Others), by Therapeutic Area (Reproductive Health and Fertility, Menopause and Hormonal Disorders, Gynaecological Disorders and Others), by Age Group (Below 30, 31-40, 41-50, and Above 51), by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Supermarket and Hypermarket, Online Channels and others), by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
Womens Health Market Research Report by Product (Contraceptive, Fertility and Ovulation Induction Drugs, Vaginal and Uterine Products, Bone Health Agents, Pain and Symptom Management, Others), by Therapeutic Area (Reproductive Health and Fertility, Menopause and Hormonal Disorders, Gynaecological Disorders and Others), by Age Group (Below 30, 31-40, 41-50, and Above 51), by Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Supermarket and Hypermarket, Online Channels and others), by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
価格 US$ 4,950  |  Market Research Future | 2026年5月 | 英文レポート
The global women’s health market was valued at USD 58,444.46 million in 2025 and is projected to reach USD 114,925.76 million by 2035. The market is expected to grow at a CAGR of 6.93% during the forecast period, driven by rising awareness of women-specif…
このレポートの詳細ページはこちら
Menopause Market Research Report by Treatment Type (Hormone Therapy, Non-Hormonal Treatment, Dietary Supplements), by Menopause Stage (Menopause, Perimenopause, Post-Menopause), by Application (Hot Flashes and Night Sweats (Vasomotor Symptoms), Vaginal Dryness and Atrophy, Sleep Disturbances, Mood Swings and Depression, Bone Health, Urinary Symptoms), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Channels), by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
Menopause Market Research Report by Treatment Type (Hormone Therapy, Non-Hormonal Treatment, Dietary Supplements), by Menopause Stage (Menopause, Perimenopause, Post-Menopause), by Application (Hot Flashes and Night Sweats (Vasomotor Symptoms), Vaginal Dryness and Atrophy, Sleep Disturbances, Mood Swings and Depression, Bone Health, Urinary Symptoms), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Channels), by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
価格 US$ 4,950  |  Market Research Future | 2026年5月 | 英文レポート
The global menopause market was valued at USD 17,628.21 million in 2025 and is projected to reach USD 30,415.70 million by 2035. The market is anticipated to expand at a CAGR of 5.7% during the forecast period, driven by rising awareness regarding women’s…
このレポートの詳細ページはこちら
Polycystic Ovarian Syndrome (PCOS) Market Research Report by Drug Class (Oral Contraceptives, Antiandrogens, Insulin Sensitizing Agents, Antidepressants, Anti-Obesity, and Others.), By Route of Administration (oral and parenteral), By Distribution Channel (Hospital pharmacies, Retail pharmacies, and Online pharmacies), and By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
Polycystic Ovarian Syndrome (PCOS) Market Research Report by Drug Class (Oral Contraceptives, Antiandrogens, Insulin Sensitizing Agents, Antidepressants, Anti-Obesity, and Others.), By Route of Administration (oral and parenteral), By Distribution Channel (Hospital pharmacies, Retail pharmacies, and Online pharmacies), and By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
価格 US$ 4,950  |  Market Research Future | 2026年5月 | 英文レポート
The global Polycystic Ovarian Syndrome market is projected to grow from USD 5,839.82 million in 2025 to USD 10,130.72 million by 2035, registering a CAGR of 5.61% during the forecast period. The market growth is driven by rising awareness of PCOS, increas…
このレポートの詳細ページはこちら
Osteoporosis Market Research Report by Drug Class (Branded, Generic), By Type (Bisphosphonates, Parathyroid Hormone Therapy, RANK Ligand (RANKL) Inhibitors, Selective Oestrogen Receptor Modulators (SERMs), Calcitonin, Sclerostin, Inhibitors, and Others.), By Route of Administration (Oral, Injectable, and Others), By Application (Primary Osteoporosis, Secondary Osteoporosis, and Others), By Gender (Male, Female), By Mechanism Action (Antiresorptive and Anabolic), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online), By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
Osteoporosis Market Research Report by Drug Class (Branded, Generic), By Type (Bisphosphonates, Parathyroid Hormone Therapy, RANK Ligand (RANKL) Inhibitors, Selective Oestrogen Receptor Modulators (SERMs), Calcitonin, Sclerostin, Inhibitors, and Others.), By Route of Administration (Oral, Injectable, and Others), By Application (Primary Osteoporosis, Secondary Osteoporosis, and Others), By Gender (Male, Female), By Mechanism Action (Antiresorptive and Anabolic), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online), By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
価格 US$ 4,950  |  Market Research Future | 2026年5月 | 英文レポート
The Global Osteoporosis Market was valued at USD 14,956.06 million in 2025 and is projected to reach USD 28,335.59 million by 2035. The market is anticipated to expand at a CAGR of 6.51% during the forecast period, driven by the rising aging population an…
このレポートの詳細ページはこちら
Early Cancer Diagnosis and Genetic Testing Market Research Report by Product Type (instruments, consumables, and services), by Technology (Chromosomal Genetic Tests, Molecular Testing, Biochemical Testing, and Cellular Testing), by Causative Factors (Infectious agent, Non- Infectious Agent), by Application (Stomach (Gastric) Cancer, Cervical Cancer, Colorectal Cancer, Liver Cancer, Oral Cancer, Lymphoma, and Others), by End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
Early Cancer Diagnosis and Genetic Testing Market Research Report by Product Type (instruments, consumables, and services), by Technology (Chromosomal Genetic Tests, Molecular Testing, Biochemical Testing, and Cellular Testing), by Causative Factors (Infectious agent, Non- Infectious Agent), by Application (Stomach (Gastric) Cancer, Cervical Cancer, Colorectal Cancer, Liver Cancer, Oral Cancer, Lymphoma, and Others), by End User (Hospitals & Clinics, Diagnostic Laboratories, and Others), by Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) Forecast till 2035
価格 US$ 4,950  |  Market Research Future | 2026年5月 | 英文レポート
The Global Early Cancer Diagnosis and Genetic Testing Market is projected to reach USD 26,416.16 million by 2035, growing at a CAGR of 14.41% during 2025?2035. Rising awareness regarding preventive healthcare and increasing adoption of precision medicine …
このレポートの詳細ページはこちら
冠動脈ステント市場レポート:タイプ別(薬剤溶出型ステント、ベアメタル冠動脈ステント、生体吸収性ステント)、生体材料別(金属系生体材料、高分子系生体材料、天然系生体材料)、留置方法別(バルーン拡張型ステント、自己拡張型ステント)、 エンドユーザー別(病院、外来手術センター、その他)、および地域別 2026-2034年
冠動脈ステント市場レポート:タイプ別(薬剤溶出型ステント、ベアメタル冠動脈ステント、生体吸収性ステント)、生体材料別(金属系生体材料、高分子系生体材料、天然系生体材料)、留置方法別(バルーン拡張型ステント、自己拡張型ステント)、 エンドユーザー別(病院、外来手術センター、その他)、および地域別 2026-2034年
Coronary Stents Market Report by Type (Drug-eluting Stents, Bare-metal Coronary Stents, Bioabsorbable Stents), Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, Natural Biomaterial), Mode of Delivery (Balloon-expandable Stents, Self-expanding Stents), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2026-2034
価格 US$ 3,999  |  IMARC Services Private Limited. | 2026年4月 | 英文レポート
The global coronary stents market size reached USD 12.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 19.3 Billion by 2034, exhibiting a growth rate (CAGR) of 4.98% during 2026-2034. North America dominates the coronary ste…
このレポートの詳細ページはこちら
「潰瘍性大腸炎市場レポート:タイプ別、分子タイプ別、薬剤タイプ別、投与経路別、流通チャネル別、地域別(2026年~2034年)」
「潰瘍性大腸炎市場レポート:タイプ別、分子タイプ別、薬剤タイプ別、投与経路別、流通チャネル別、地域別(2026年~2034年)」
Ulcerative Colitis Market Report by Type, Molecule Type, Drug Type, Route of Administration , Distribution Channel , and Region 2026-2034
価格 US$ 3,999  |  IMARC Services Private Limited. | 2026年4月 | 英文レポート
The global ulcerative colitis market size reached USD 8.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 13.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.63% during 2026-2034. The market is experiencing growth due …
このレポートの詳細ページはこちら
製品、用途、エンドユーザー、地域別のグリコミクス市場規模、シェア、動向および予測(2026年~2034年)
製品、用途、エンドユーザー、地域別のグリコミクス市場規模、シェア、動向および予測(2026年~2034年)
Glycomics Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034
価格 US$ 3,999  |  IMARC Services Private Limited. | 2026年4月 | 英文レポート
The global glycomics market size was valued at USD 1.9 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 4.7 Billion by 2034, exhibiting a CAGR of 10.19% from 2026-2034. North America currently dominates the market, holding a…
このレポートの詳細ページはこちら
コンティニュアス・グルコース・モニタリング(CGM)システム市場:構成要素、人口統計、エンドユーザー、地域別の市場規模、シェア、動向および予測(2026年~2034年)
コンティニュアス・グルコース・モニタリング(CGM)システム市場:構成要素、人口統計、エンドユーザー、地域別の市場規模、シェア、動向および予測(2026年~2034年)
Continuous Glucose Monitoring Systems Market Size, Share, Trends and Forecast by Component, Demographics, End User, and Region, 2026-2034
価格 US$ 3,999  |  IMARC Services Private Limited. | 2026年4月 | 英文レポート
The global continuous glucose monitoring systems market size was valued at USD 7.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 11.0 Billion by 2034, exhibiting a CAGR of 4.38% from 2026-2034. North America currently dom…
このレポートの詳細ページはこちら
医療用コグニティブ・コンピューティング市場規模、シェア、動向および予測:技術別、導入形態別、最終用途別、地域別(2026年~2034年)
医療用コグニティブ・コンピューティング市場規模、シェア、動向および予測:技術別、導入形態別、最終用途別、地域別(2026年~2034年)
Healthcare Cognitive Computing Market Size, Share, Trends and Forecast by Technology, Deployment Mode, End Use, and Region, 2026-2034
価格 US$ 3,999  |  IMARC Services Private Limited. | 2026年4月 | 英文レポート
The global healthcare cognitive computing market size was valued at USD 7.0 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 26.1 Billion by 2034, exhibiting a CAGR of 15.29% from 2026-2034. North America currently dominates…
このレポートの詳細ページはこちら
製品タイプ別(ビスホスホネート、カルシトニン、RANKリガンド阻害薬、副甲状腺ホルモン療法(PTH)、選択的エストロゲン受容体モジュレーター(SERMs)、スクレロスチン阻害薬、その他)、投与経路別(経口、注射剤、その他)、および地域別の骨粗鬆症治療薬市場レポート 2026-2034年
製品タイプ別(ビスホスホネート、カルシトニン、RANKリガンド阻害薬、副甲状腺ホルモン療法(PTH)、選択的エストロゲン受容体モジュレーター(SERMs)、スクレロスチン阻害薬、その他)、投与経路別(経口、注射剤、その他)、および地域別の骨粗鬆症治療薬市場レポート 2026-2034年
Osteoporosis Drugs Market Report by Product Type (Bisphosphonates, Calcitonin, Rank Ligand Inhibitor, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Sclerostin Inhibitor, and Others), Route of Administration (Oral, Injectable, and Others), and Region 2026-2034
価格 US$ 3,999  |  IMARC Services Private Limited. | 2026年5月 | 英文レポート
The global osteoporosis drugs market size reached USD 18.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.4 Billion by 2034, exhibiting a growth rate (CAGR) of 3.82% during 2026-2034.Osteoporosis is a disease that causes …
このレポートの詳細ページはこちら
検査種別(甲状腺検査、インスリン検査、ヒト絨毛性ゴナドトロピン検査、プロラクチン検査、黄体形成ホルモン検査、プロゲステロン検査、その他)、技術(免疫測定法、タンデム質量分析法、センサー技術、LC-MS、その他)、 最終用途別(病院、外来診療センター、臨床検査室、その他)、および地域別 2026-2034年
検査種別(甲状腺検査、インスリン検査、ヒト絨毛性ゴナドトロピン検査、プロラクチン検査、黄体形成ホルモン検査、プロゲステロン検査、その他)、技術(免疫測定法、タンデム質量分析法、センサー技術、LC-MS、その他)、 最終用途別(病院、外来診療センター、臨床検査室、その他)、および地域別 2026-2034年
Endocrine Testing Market Report by Test Type (Thyroid Test, Insulin Test, Human Chorionic Gonadotropin Test, Prolactin Test, Luteinizing Hormone Test, Progesterone Test, and Others), Technology (Immunoassay, Tandem Mass Spectroscopy, Sensor Technology, LC-MS, and Others), End Use (Hospitals, Ambulatory Care Centers, Clinical Laboratories, and Others), and Region 2026-2034
価格 US$ 3,999  |  IMARC Services Private Limited. | 2026年5月 | 英文レポート
The global endocrine testing market size reached USD 12.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 22.0 Billion by 2034, exhibiting a growth rate (CAGR) of 6.02% during 2026-2034.Endocrine testing refers to the medical…
このレポートの詳細ページはこちら
コンパニオン・ダイアグノスティクス市場レポート:製品・サービス別(アッセイ、キットおよび試薬、ソフトウェアおよびサービス)、技術別(免疫組織化学(IHC)、 ポリメラーゼ連鎖反応(PCR)、イン・シトゥハイブリダイゼーション(ISH)、リアルタイムPCR(RT-PCR)、遺伝子シーケンシング、その他)、適応症(がん、神経疾患、感染症、心血管疾患、その他)、 エンドユーザー別(製薬・バイオ医薬品企業、検査機関、受託研究機関、その他)、および地域別 2026-2034年
コンパニオン・ダイアグノスティクス市場レポート:製品・サービス別(アッセイ、キットおよび試薬、ソフトウェアおよびサービス)、技術別(免疫組織化学(IHC)、 ポリメラーゼ連鎖反応(PCR)、イン・シトゥハイブリダイゼーション(ISH)、リアルタイムPCR(RT-PCR)、遺伝子シーケンシング、その他)、適応症(がん、神経疾患、感染症、心血管疾患、その他)、 エンドユーザー別(製薬・バイオ医薬品企業、検査機関、受託研究機関、その他)、および地域別 2026-2034年
Companion Diagnostics Market Report by Product & Service (Assays, Kits and Reagents, Software and Services), Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, and Others), Indication (Cancer, Neurological Diseases, Infectious Diseases, Cardiovascular Diseases, and Others), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Region 2026-2034
価格 US$ 3,999  |  IMARC Services Private Limited. | 2026年5月 | 英文レポート
The global companion diagnostics market size reached USD 8.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 24.0 Billion by 2034, exhibiting a growth rate (CAGR) of 11.86% during 2026-2034.North America leads the market attr…
このレポートの詳細ページはこちら
乳房画像診断市場の規模、シェア、動向および予測:技術別、エンドユーザー別、地域別(2026年~2034年)
乳房画像診断市場の規模、シェア、動向および予測:技術別、エンドユーザー別、地域別(2026年~2034年)
Breast Imaging Market Size, Share, Trends and Forecast by Technology, End User, and Region, 2026-2034
価格 US$ 3,999  |  IMARC Services Private Limited. | 2026年5月 | 英文レポート
The global breast imaging market size was valued at USD 5.2 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 9.6 Billion by 2034, exhibiting a CAGR of 6.82% from 2026-2034. North America currently dominates the market, holdi…
このレポートの詳細ページはこちら
H1N1ワクチン市場レポート:ワクチン種類別(筋肉内、経鼻、皮内)、市場形態別(公的、民間)、地域別(2026年~2034年)
H1N1ワクチン市場レポート:ワクチン種類別(筋肉内、経鼻、皮内)、市場形態別(公的、民間)、地域別(2026年~2034年)
H1N1 Vaccines Market Report by Vaccine Type (Intramuscular, Intranasal, Intradermal), Market Type (Public, Private), and Region 2026-2034
価格 US$ 3,999  |  IMARC Services Private Limited. | 2026年5月 | 英文レポート
The global H1N1 vaccines market size reached USD 4.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.7 Billion by 2034, exhibiting a growth rate (CAGR) of 3.87% during 2026-2034. The increasing healthcare concerns, signific…
このレポートの詳細ページはこちら
治療法別(薬物療法(NSAIDs、経口避妊薬、ゴナドトロピン放出ホルモンアゴニスト・アンタゴニスト、その他)、鍼治療、外科手術)、エンドユーザー別(病院・クリニック、在宅医療、その他)、地域別(北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ)の子宮内膜症市場調査レポート:2035年までの予測
治療法別(薬物療法(NSAIDs、経口避妊薬、ゴナドトロピン放出ホルモンアゴニスト・アンタゴニスト、その他)、鍼治療、外科手術)、エンドユーザー別(病院・クリニック、在宅医療、その他)、地域別(北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ)の子宮内膜症市場調査レポート:2035年までの予測
Endometriosis Market Research Report by Treatment Type [Medication (NSAIDs, Oral Contraceptive, Gonadotropin Releasing Hormone Agonists Antagonists, Others), Acupuncture Therapy, Surgery], by End User (Hospitals & Clinics, Homecare Settings, Others), by Region (North America, Europe, Asia Pacific, Latin America, MEA) Forecast till 2035
価格 US$ 4,950  |  Market Research Future | 2026年4月 | 英文レポート
The global endometriosis market was valued at USD 3,030.79 million in 2025 and is projected to reach USD 9,786.23 million by 2035. The market is expected to expand at a CAGR of 12.5% during the forecast period from 2026 to 2035, driven by rising awarene…
このレポートの詳細ページはこちら
世界のバキュロウイルスタンパク質発現市場の成長(現状と展望)2026-2032年
世界のバキュロウイルスタンパク質発現市場の成長(現状と展望)2026-2032年
Global Baculovirus Protein Expression Market Growth (Status and Outlook) 2026-2032
価格 US$ 3,660  |  LP Information | 2026年5月 | 英文レポート
The global Baculovirus Protein Expression market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.A baculovirus expression vector (BEV) is a recombinant baculovirus with a do…
このレポートの詳細ページはこちら

ページTOPに戻る